Shenzhen Zhongke Microlight Medical Device Technology Co., Ltd. (hereinafter referred to as "Microlight Medical") recently announced that it has successfully obtained a strategic investment of more than 100 million yuan. The financing was jointly invested by Huarui Investment, Guangzhou Industrial Investment Capital and Chasing Light Hard Technology. The funds will be mainly used for the research and development of new laser medical products, clinical registration, and expansion of overseas markets.
Since its establishment in 2012, Microlight Medical has been a pioneer and innovative leader in the field of laser medicine in China. The company brings together core teams from Tsinghua University, Chinese Academy of Sciences, West China Medical and other well-known universities, focusing on the innovation of laser medical technology, independent R&D and production of products. Microlight Medical not only has independent capabilities in the research and development of software, hardware and consumables, but also is one of the few domestic enterprises with independent research and development of core components. Its products have been widely recognized by clinical experts for their excellent results, and have achieved remarkable results in the market with a compound annual growth rate of more than 80%, especially its coronary OCT products have the first market share in the domestic market.
Microlight Medical not only focuses on the diagnosis and function of the product, but also uses advanced optoelectronic technology and the concept of medical and engineering integration to launch a number of innovative products in the three core medical fields of coronary artery, peripheral and neurological. The company is committed to building an innovative platform of "integrated diagnosis and treatment" covering a variety of diseases.
Mr. Zhu Rui, the founder of Microlight Medical, expressed his gratitude for the financing and pointed out that the post-pandemic era has brought more opportunities to companies with innovative capabilities and modern business thinking. He stressed that the financing will accelerate the company's technology research and development and product promotion. Mr. Zhu Lifeng, head of investment and financing, also said that multiple rounds of financing have helped the company find like-minded partners to work together to build a leading laser medical innovation platform.
Representatives of investors are also full of expectations for the future of Microlight Medical, believing that the company's products in the fields of cardiovascular, cerebrovascular and peripheral vascular can provide advanced "diagnosis + treatment" solutions, and are expected to become the world's leading laser medical innovation platform and make greater contributions to human health.